Public filings / CAPR on Yahoo Finance (opens in a new tab)
CAPR: insider buying, 13F holders, analyst moves
Capricor Therapeutics Inc - US
A summary of public filings about Capricor Therapeutics Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
3 of our 100 managers hold CAPR
Combined reported value $42.7M; 1 sold out since Q1 2026.
Holders among our 100 managers: 0 in Q3 2023, 3 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RA Capital | $36.3M | 0.32% | Unchanged |
| RTW Investments | $6.0M | 0.05% | Unchanged |
| Tudor Investment | $381K | 0.00% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.